Antitope Limited, UK. Announces Research Agreement With GlaxoSmithKline plc - 2nd January 2007 - Antitope Ltd., a leading company with technologies for the assessment and removal of immunogenicity in therapeutic antibodies/proteins, announced the signing of a research agreement with GlaxoSmithKline plc (GSK). Under the collaboration, Antitope will apply its technologies to a selected group of potential therapeutics developed by GSK.